A groundbreaking new treatment option may revolutionize the way early-stage HER2-positive breast cancer is managed. Trastuzumab emtansine, also known as T-DM1, has shown remarkable efficacy in keeping 98% of women…

Subscribe Now for Real-time Updates on the Latest Stories!
Who Weekly is a popular podcast that categorizes celebrities into "Whos" (less famous individuals) and "Thems" (universally recognized celebrities). This…
Plasticizers, commonly found in products such as PVC, paints, and cosmetics, have been found to have negative effects on normal…
The rapid advancement of artificial intelligence (AI) in the healthcare sector has sparked optimism among organizations looking to address the…
State Medicaid programs have historically not covered the new class of weight loss drugs for obesity, but recent data suggests…
contribute to the economy through their work, should they still be eligible for disability benefits? What is the cost-benefit analysis…
Philadelphia Hospitals Make Groundbreaking Decision to Stop Using Race-Adjusted Algorithms A significant development in healthcare was announced yesterday as a…
Patients across the U.K. are facing travel difficulties, communication issues, and stress that are preventing them from attending their hospital…
Food science is a complex field that faces a fundamental barrier to scientific certainty: people eat foods, not just isolated…
Sign in to your account